The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s buccal drug delivery system market report forecasts the buccal drug delivery system market size to grow to $4.76 Billion by 2027, with a CAGR (compound annual growth rate) of more than 9%.

Learn More On The Buccal Drug Delivery System Market Report 2023 – https://www.thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report

Buccal Drug Delivery System Market Size Forecast
The global buccal drug delivery system market is expected to grow from $2.97 billion in 2022 to $2.97 billion in 2023 at a compound annual growth rate (CAGR) of 10.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The buccal drug delivery systems market is expected to grow to $4.76 billion in 2027 at a CAGR of 9.7%.

North America held the largest buccal drug delivery system market share.

Key Buccal Drug Delivery System Market Driver ­– Rise In The Prevalence Of Chronic Diseases
For instance, in September 2020, according to a study report issued by the American Action Forum, chronic illness frequency and expenses are increasing in the United States. Chronic illness is anticipated to continue increasing as the incidence of illness among children and young people increases. Chronic illness is a significant healthcare issue since it costs the US $3.7 trillion annually, or about 19.6% of the GDP, and is rising. Therefore, the rising prevalence of chronic diseases drives the buccal drug delivery systems market.

Request for A Sample Of The Global Buccal Drug Delivery System Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8290&type=smp

Key Buccal Drug Delivery System Market Trend – Investmenting In Injectable Drug Delivery Systems
Major pharmaceutical companies are investing in drug delivery systems to sustain their position in the market. For instance, in September 2021, Novartis, a Switzerland-based pharmaceutical company, invested approximately $40 million in Credence MedSystems, a US-based company that develops innovative drug delivery systems. The aim of the investment is to boost the production of injectable drug delivery systems.

Buccal Drug Delivery System Market Segment
1) By Type: Sublingual, Buccal Tablets and Lozenges, Oral Sprays
2) By Application: Pain Management, Smoking Cessation, Angina Pectoris
3) By End-User: Hospitals, Ambulatory Centers, Other End-Users

Buccal Drug Delivery System Market Major Players and Strategies
Major players in the buccal drug delivery system market are Teva Pharmaceuticals Limited, Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior Pharmaceuticals, Generex Biotechnology, Catalent, Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, MedLab, AstraZeneca, F. Hoffmann-La Roche Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Novartis AG, and Novo Nordisk A/S.

In November 2020, Novo Nordisk, a Denmark-based pharmaceutical company, acquired Emisphere Technologies for a total amount of $ 1.8 billion. With this acquisition, Novo Nordisk eliminates any future royalty liabilities to Emisphere and MHR and gains full access to the Eligen SNAC technology platform, which enables it to diversify its oral drug portfolio assets across therapeutic areas. Emisphere Technologies is a US-based drug delivery company that develops improved oral formulations and active pharmaceutical ingredients.

The Buccal Drug Delivery System Global Market Report 2023 covers regional data on buccal drug delivery system market size, buccal drug delivery system market trends and drivers, opportunities, strategies, and buccal drug delivery system market competitor analysis. The countries covered in the buccal drug delivery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The buccal drug delivery system refers to the injection of the desired medicine through the buccal mucosal membrane lining of the mouth cavity. This method is effective for administering mucosal and transmucosal drugs. Mucosal drug delivery aims for site-specific drug release on the mucosa, whereas transmucosal permeation entails drug absorption across the mucosal barrier and into the systemic circulation.

View More Reports Related To The Buccal Drug Delivery System Market –
Drug Delivery Devices Global Market Report 2023
Implantable Drug Delivery Devices Global Market Report 2023
Topical Drug Delivery Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: